CUV 2.71% $23.47 clinuvel pharmaceuticals limited

phase 11b trial results, page-3

  1. 22,691 Posts.
    This is marvellous stuff:
    "Importantly, the percentage increase in melanin density for fairer skin types (Fitzpatrick I/I I) was approximately double that for those with darker skin types (Fitzpatricklll/IV)".

    "Dr Humphrey also added, "It is worthwhile noting that half the number of volunteers who subjectively declared themselves as having the ability to tan and rarely burn (Fitzpatrick 11 I/I V skin type) turned out, in fact, to be Fitzpatrick Type I/I I (usually burn/ tan with difficulty).

    The use of Melanotan in conjunction with other skin protection methods should ensure that people have the ability to protect themselves better from the harmful effects of UV radiation".

    This is big news because it was here that perhaps some difficulty could have been experienced.

    It does mean that the potential market is being expanded all the time.

    This is a biggie!


watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.159B
Open High Low Value Volume
$23.00 $23.57 $23.00 $2.471M 105.8K

Buyers (Bids)

No. Vol. Price($)
1 206 $23.44

Sellers (Offers)

Price($) Vol. No.
$23.47 17 1
View Market Depth
Last trade - 16.10pm 25/09/2020 (20 minute delay) ?
0.620 ( 2.82 %)
Open High Low Volume
$23.04 $23.55 $23.03 4152
Last updated 15.59pm 25/09/2020 (live) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.